Literature DB >> 29855778

Intraoperative displacement of a Perceval sutureless prosthesis.

Giosuè Falcetta1, Clemente Pascarella1, Pietro Bertini2, Stefano Pratali1, Uberto Bortolotti3.   

Abstract

We describe a patient with mitral incompetence and aortic stenosis who underwent mitral valve repair and aortic valve replacement using a Perceval sutureless bioprosthesis. After weaning from cardiopulmonary bypass, repeated mitral valve repair was required due to residual mitral regurgitation. During this procedure, the aortic prosthesis was displaced, most likely by undue inadvertent traction on the atrial retractor, requiring its removal and reinsertion. When employing a sutureless valve gentle manipulation of the heart is mandatory to avoid possible adverse events as that herein described. Should this happen, the Perceval valve can be easily removed and repositioned.

Entities:  

Keywords:  Aortic valve replacement; Mitral valve repair; Sutureless bioprostheses

Mesh:

Year:  2018        PMID: 29855778     DOI: 10.1007/s11748-018-0951-9

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  7 in total

1.  A supra-annular malposition of the Perceval S sutureless aortic valve: the 'χ-movement' removal technique and subsequent reimplantation.

Authors:  Giuseppe Santarpino; Steffen Pfeiffer; Giovanni Concistrè; Theodor Fischlein
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-04-25

2.  Clinical and haemodynamic outcomes in 658 patients receiving the Perceval sutureless aortic valve: early results from a prospective European multicentre study (the Cavalier Trial)†.

Authors:  François Laborde; Theodor Fischlein; Kavous Hakim-Meibodi; Martin Misfeld; Thierry Carrel; Marian Zembala; Francesco Madonna; Bart Meuris; Axel Haverich; Malakh Shrestha
Journal:  Eur J Cardiothorac Surg       Date:  2015-08-04       Impact factor: 4.191

3.  Sutureless, rapid deployment valves and stented bioprosthesis in aortic valve replacement: recommendations of an International Expert Consensus Panel.

Authors:  Borut Gersak; Theodor Fischlein; Thierry A Folliguet; Bart Meuris; Kevin H T Teoh; Simon C Moten; Marco Solinas; Antonio Miceli; Peter J Oberwalder; Manfredo Rambaldini; Gopal Bhatnagar; Michael A Borger; Denis Bouchard; Olivier Bouchot; Stephen C Clark; Otto E Dapunt; Matteo Ferrarini; Guenther Laufer; Carmelo Mignosa; Russell Millner; Philippe Noirhomme; Steffen Pfeiffer; Xavier Ruyra-Baliarda; Malakh Shrestha; Rakesh M Suri; Giovanni Troise; Anno Diegeler; Francois Laborde; Marc Laskar; Hani K Najm; Mattia Glauber
Journal:  Eur J Cardiothorac Surg       Date:  2015-10-29       Impact factor: 4.191

4.  Expanding the indication for sutureless aortic valve replacement to patients with mitral disease.

Authors:  Tam Hoang Minh; Amine Mazine; Ismail Bouhout; Ismail El-Hamamsy; Michel Carrier; Denis Bouchard; Philippe Demers
Journal:  J Thorac Cardiovasc Surg       Date:  2014-01-15       Impact factor: 5.209

5.  European multicentre experience with the sutureless Perceval valve: clinical and haemodynamic outcomes up to 5 years in over 700 patients.

Authors:  Malakh Shrestha; Theodore Fischlein; Bart Meuris; Willem Flameng; Thierry Carrel; Francesco Madonna; Martin Misfeld; Thierry Folliguet; Axel Haverich; Francois Laborde
Journal:  Eur J Cardiothorac Surg       Date:  2015-03-06       Impact factor: 4.191

6.  Aortic valve replacement and concomitant procedures with the Perceval valve: results of European trials.

Authors:  Malakh Shrestha; Thierry A Folliguet; Steffen Pfeiffer; Bart Meuris; Thierry Carrel; Matthias Bechtel; Willem J Flameng; Theodor Fischlein; François Laborde; Axel Haverich
Journal:  Ann Thorac Surg       Date:  2014-08-05       Impact factor: 4.330

7.  Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database.

Authors:  James M Brown; Sean M O'Brien; Changfu Wu; Jo Ann H Sikora; Bartley P Griffith; James S Gammie
Journal:  J Thorac Cardiovasc Surg       Date:  2009-01       Impact factor: 5.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.